DoW Breast Cancer, Breakthrough Award Levels 1 and 2
- Not stated
- 6
- Sep 3, 2026
Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.
Summary
The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception…
Preparing an application?
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
More from Defense Health Agency Contracting Activity - DHACA
DoW Spinal Cord Injury, Clinical Translation Research Award
DoW Vision, Clinical Trial Award
DoW Spinal Cord Injury, Clinical Trial Award
DoW Spinal Cord Injury, Translational Research Award
Everything open from Defense Health Agency Contracting Activity - DHACA
Related by subject
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
$150k
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
$300k